139 related articles for article (PubMed ID: 11256963)
21. Sphingosylphosphorylcholine protects cardiomyocytes against ischemic apoptosis via lipid raft/PTEN/Akt1/mTOR mediated autophagy.
Yue HW; Liu J; Liu PP; Li WJ; Chang F; Miao JY; Zhao J
Biochim Biophys Acta; 2015 Sep; 1851(9):1186-93. PubMed ID: 25871970
[TBL] [Abstract][Full Text] [Related]
22. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
Hong CM; Zheng QS; Liu XT; Shang FJ; Wang HT; Jiang WR
Cardiology; 2009; 112(3):180-7. PubMed ID: 18679026
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipids inhibit vimentin-dependent cell migration.
Hyder CL; Kemppainen K; Isoniemi KO; Imanishi SY; Goto H; Inagaki M; Fazeli E; Eriksson JE; Törnquist K
J Cell Sci; 2015 Jun; 128(11):2057-69. PubMed ID: 25908861
[TBL] [Abstract][Full Text] [Related]
24. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro.
Bischoff A; Czyborra P; Fetscher C; Meyer Zu Heringdorf D; Jakobs KH; Michel MC
Br J Pharmacol; 2000 Aug; 130(8):1871-7. PubMed ID: 10952677
[TBL] [Abstract][Full Text] [Related]
25. Sphingosylphosphorylcholine inhibits melanin synthesis via pertussis toxin-sensitive MITF degradation.
Kim DS; Park SH; Kwon SB; Kwon NS; Park KC
J Pharm Pharmacol; 2010 Feb; 62(2):181-7. PubMed ID: 20487197
[TBL] [Abstract][Full Text] [Related]
26. Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts.
Kye KC; Chae EK; Piao YJ; Park S; Park JK; Kim CD; Lee JH; Suhr KB
J Invest Dermatol; 2004 Jun; 122(6):1365-71. PubMed ID: 15175025
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner.
Bischoff A; Czyborra P; Meyer Zu Heringdorf D; Jakobs KH; Michel MC
Br J Pharmacol; 2000 Aug; 130(8):1878-83. PubMed ID: 10952678
[TBL] [Abstract][Full Text] [Related]
28. Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4.
Mintert E; Bösche LI; Rinne A; Timpert M; Kienitz MC; Pott L; Bender K
J Physiol; 2007 Nov; 585(Pt 1):3-13. PubMed ID: 17884923
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.
Mathieson FA; Nixon GF
Br J Pharmacol; 2006 Feb; 147(4):351-9. PubMed ID: 16402047
[TBL] [Abstract][Full Text] [Related]
30. Hydrolysis of sphingosylphosphocholine by neutral sphingomyelinases.
Miura Y; Gotoh E; Nara F; Nishijima M; Hanada K
FEBS Lett; 2004 Jan; 557(1-3):288-92. PubMed ID: 14741383
[TBL] [Abstract][Full Text] [Related]
31. Acetylcholine-sensitive muscarinic K+ channels in mammalian ventricular myocytes.
Koumi S; Wasserstrom JA
Am J Physiol; 1994 May; 266(5 Pt 2):H1812-21. PubMed ID: 8203580
[TBL] [Abstract][Full Text] [Related]
32. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.
Xu Y; Zhu K; Hong G; Wu W; Baudhuin LM; Xiao Y; Damron DS
Nat Cell Biol; 2000 May; 2(5):261-7. PubMed ID: 10806476
[TBL] [Abstract][Full Text] [Related]
33. Sphingosylphosphorylcholine is a bona fide mediator regulating heart rate.
Liliom K; Bünemann M; Sun G; Miller D; Desiderio DM; Brandts B; Bender K; Pott L; Nusser N; Tigyi G
Ann N Y Acad Sci; 2000 Apr; 905():308-10. PubMed ID: 10818471
[No Abstract] [Full Text] [Related]
34. Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes.
Wilken A; Tawfik-Schlieper H; Klotz KN; Schwabe U
Mol Pharmacol; 1990 Jun; 37(6):916-20. PubMed ID: 2163017
[TBL] [Abstract][Full Text] [Related]
35. Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis.
Boguslawski G; Lyons D; Harvey KA; Kovala AT; English D
Biochem Biophys Res Commun; 2000 Jun; 272(2):603-9. PubMed ID: 10833459
[TBL] [Abstract][Full Text] [Related]
36. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat.
Murch O; Abdelrahman M; Collino M; Gallicchio M; Benetti E; Mazzon E; Fantozzi R; Cuzzocrea S; Thiemermann C
Crit Care Med; 2008 Feb; 36(2):550-9. PubMed ID: 18216604
[TBL] [Abstract][Full Text] [Related]
37. Pilocarpine modulates the cellular electrical properties of mammalian hearts by activating a cardiac M3 receptor and a K+ current.
Wang H; Shi H; Lu Y; Yang B; Wang Z
Br J Pharmacol; 1999 Apr; 126(8):1725-34. PubMed ID: 10372814
[TBL] [Abstract][Full Text] [Related]
38. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor.
Jin Y; Damaj BB; Maghazachi AA
Eur J Immunol; 2005 Sep; 35(9):2699-708. PubMed ID: 16078278
[TBL] [Abstract][Full Text] [Related]
39. Indomethacin differentiates the renal effects of sphingosine-1-phosphate and sphingosylphosphorylcholine.
Czyborra C; Bischoff A; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):37-44. PubMed ID: 16521006
[TBL] [Abstract][Full Text] [Related]
40. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis.
Lee HY; Shin EH; Bae YS
Acta Pharmacol Sin; 2006 Oct; 27(10):1359-66. PubMed ID: 17007744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
